Back
Kymera Therapeutics Vs. Denali Therapeutics Industry Stock Comparison
Buy
67
KYMR
Kymera Therapeutics
Last Price:
49.80
Seasonality Move:
36.05%
Buy
54
DNLI
Denali Therapeutics
Last Price:
30.94
Seasonality Move:
17.79%
Buy
67
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $49.79. The Score for KYMR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Denali Therapeutics (DNLI)
is a Buy
Is Denali Therapeutics a Buy, Sell or Hold?
- The current Denali Therapeutics [DNLI] share price is $30.92. The Score for DNLI is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- DNLI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $49.79
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
DNLI Stock Price Chart
What is Denali Therapeutics's stock price today?
-
The Denali Therapeutics share price today is $30.92
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing slight selling pressure.
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.03 | Buy |
| Relative Strength Index (14 RSI): | 60.95 | Buy |
| Chaikin Money Flow: | 714664 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.35 - 48.65) | Buy |
| Bollinger Bands (100): | (33.45 - 45.77) | Buy |
DNLI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.94 | Buy |
| Relative Strength Index (14 RSI): | 77.58 | Buy |
| Chaikin Money Flow: | -82376 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.79 - 29.05) | Buy |
| Bollinger Bands (100): | (19.29 - 25.67) | Buy |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 47.08 | Buy |
| 20-day SMA: | 47.29 | Buy |
| 50-day SMA: | 45.16 | Buy |
| 200-day SMA: | 36.65 | Buy |
| 8-day EMA: | 47.74 | Buy |
| 20-day EMA: | 46.8 | Buy |
| 50-day EMA: | 44.35 | Buy |
| 200-day EMA: | 36.97 | Buy |
DNLI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.95 | Buy |
| 20-day SMA: | 27.05 | Buy |
| 50-day SMA: | 24.72 | Buy |
| 200-day SMA: | 20.71 | Buy |
| 8-day EMA: | 29.81 | Buy |
| 20-day EMA: | 27.7 | Buy |
| 50-day EMA: | 25.28 | Buy |
| 200-day EMA: | 22.38 | Buy |
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.15 per share, a decrease next quarter of $0.10 per share, a decrease this year of $0.22 per share, and a decrease next year of $0.53 per share.
Denali Therapeutics Earnings Growth & DNLI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.52 per share, and a decrease next year of $0.07 per share.
Kymera Therapeutics Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Denali Therapeutics Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||